Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) SHH

24.64

-0.14(-0.56%)

Updated at December 05 10:24AM

Currency In CNY

Valuation

Market Cap5.77B
Enterprise Value2.85B
P/E Ratio-9.89
PEG Ratio-0.85
Price/Sales Ratio5.67
Price/Book Ratio0.75
Enterprise/Revenue3.15
Enterprise/EBITDA-5.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.57
Operating Margin-0.63

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.07

Income Statement

Revenue827.92M
Revenue/Share4.4
Gross Profit59.91M
EBITDA-359.68M
Net Income-529.02M
Diluted EPS-2.6

Balance Sheet

Total Cash2.64B
Total Cash/Share13.81
Total Debt310.03M
Total Debt/Equity0.05
Current Ratio4.28
Book Value Per Share33.92

Price History

52-Week Change-22.08
52-Week High36
52-Week Low21.14
Moving Average 50 Days25.93
Moving Average 200 Days26.59

Statistics

Average Volume2.26M
Shares Outstanding192.7M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor6:5
Last Split DateJune 26, 2023